Anterior cruciate ligament (ACL) tears are one of the most common orthopaedic injuries seen in the United States, especially in young active individuals.[@bib1] In the United States, approximately 200,000 ACL reconstructions are performed per year.[@bib2] Since the first described ACL reconstruction in the early 20th century, the amount of research into the pathology of ACL injuries and need for surgical reconstruction has grown drastically, especially over the past half century.[@bib3] As the understanding of ACL anatomy and biomechanics has improved over time, new surgical techniques have been introduced and refined.

Optimal graft type remains one of the most important and most debated surgical decisions in ACL reconstruction. In the late 1970s and early 1980s, use of bone--patellar tendon--bone graft gained popularity and is still considered the gold standard with which other grafts are compared. Since that time, hamstring grafts have gained popularity as an alternative option, largely owing to morbidity associated with patellar tendon autografts.[@bib3] Although patellar tendon and hamstring grafts remain widely used today, another alternative graft choice for ACL reconstruction has been gaining in popularity, the quadriceps tendon (QT). A technique for use of the QT as an autograft donor site for ACL reconstruction was introduced in 1979 by Marshall et al.[@bib4] Since its introduction, the QT has gained popularity for use as a graft source because of favorable biomechanics, low donor-site morbidity, large cross-sectional area of the graft, predictability, ease of harvest, and graft versatility.[@bib5]^,^[@bib6]

Because there is no consensus on the optimal graft choice for ACL reconstruction, this continues to be a prevalent topic of research, often focusing on the more popular patellar tendon or hamstring grafts. However, as the use of QT in ACL reconstruction increases, so does its interest as a topic of scientific investigation. In an effort to evaluate the increasing popularity of QT autografts, the purpose of this study was to perform a systematic review with quantitative and qualitative analysis of publications to date focusing on the use of QT autografts in ACL reconstruction. In addition to evaluating the number of publications regarding QT ACL reconstruction over time, we sought to define the regional variability, type of publication, level of evidence, journal of publication, and type of QT graft used. The hypothesis of this study was that a systematic review of ACL literature would show increasing scientific interest in the QT as a source for autograft ACL reconstruction.

Methods {#sec1}
=======

The PubMed and Scopus databases were queried for journal articles focused on QT autografts being used for ACL reconstruction published through December 31, 2018. The search was performed using the following queries: (1) (quadriceps tendon\[All Fields\]) AND (anterior cruciate\[All Fields\]) and (2) (quadriceps tendon\[All Fields\]) AND (ACL\[All Fields\]). Google Scholar and the references of the articles found were reviewed to identify any articles not included in the primary search. These publications were then analyzed and differentiated by the following publication characteristics: year of publication, QT graft type evaluated (QT or central QT, quadriceps tendon--bone \[QT-B\], or quadriceps tendon--bone--patellar tendon \[QT-B-PT\]), journal of publication, country of the corresponding author's affiliation, and geographic region of the corresponding author's affiliation. The publications evaluating clinical outcomes were also analyzed for the level of evidence according to Oxford Centre for Evidence-Based Medicine guidelines.[@bib7] The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed throughout the analyses.[@bib8]

Articles discussing the use of QT autograft for primary and revision ACL reconstruction and/or biomechanical evaluation of QT grafts were included. Clinical studies that did not exclusively evaluate the QT graft were included if greater than 25% of the evaluated ACL reconstructions used QT grafts. If a publication evaluated the use of more than 1 graft type (e.g., a portion of patients received QT grafts and a portion received QT-B-PT grafts) or did not specify the QT graft type, the publication was counted in the mixed/unspecified category. Studies were excluded if they evaluated QT allografts, evaluated QT grafts for non-ACL reconstruction, were conducted in animal models, or failed to identify the proportion of QT grafts when multiple grafts were used. Editorial commentaries and book chapters were excluded.

Results {#sec2}
=======

Search queries 1 and 2 collectively yielded 1,179 results from PubMed and 3,524 results from Scopus, for a total of 4,703 results. The results were cross-referenced for duplicates, yielding 2,738 unique publications. After initial screening, 503 publications were assessed for eligibility. A Google Scholar search was then conducted, which revealed that no relevant articles were missed by the initial queries. The 503 full-text articles were filtered based on our inclusion and exclusion criteria, which yielded 187 publications to be included in the study ([Fig 1](#fig1){ref-type="fig"}). Of the publications focusing on QT for ACL reconstruction, 62% (115 of 187) were published within the past 10 years and 30% (56 of 187) were published within the past 3 years ([Fig 2](#fig2){ref-type="fig"}). Use of the QT-B-PT graft was common in early studies when QT was first introduced as an alternative graft. Of the 25 studies published in the first 2 decades since the introductory article of Marshall et al.[@bib4] in 1979, 32% (8 of 25) evaluated the QT as part of a QT-B-PT graft ([Fig 2](#fig2){ref-type="fig"}). However, in the 162 studies published since then (87% of the total publications), QT grafts were evaluated as either QT-B grafts or QT or central QT grafts ([Fig 2](#fig2){ref-type="fig"}). In total, 96% of publications (179 of 187) evaluated QT grafts, QT-B grafts, or a combination of QT and QT-B grafts. Most studies focusing on QT graft for ACL reconstruction were published in arthroscopy-focused or sports medicine--focused journals ([Fig 3](#fig3){ref-type="fig"}). The United States was the country with the most publications focusing on QT grafts for ACL reconstruction ([Fig 4](#fig4){ref-type="fig"}). However, when publications were evaluated by region, Europe was responsible for the majority ([Fig 5](#fig5){ref-type="fig"}). Most articles evaluated clinical outcomes (n = 112, 57%). Of the clinical outcome studies, 72% were Level of Evidence III ([Fig 6](#fig6){ref-type="fig"}). Of the 16 Level of Evidence I or II publications, 11 were published within the past 5 years.Fig 1Preferred Reporting Items for Systematic Reviews and Meta-analyses flow diagram showing publication identification and screening process for inclusion. Publications were excluded (asterisk) if they were editorial commentaries, evaluated quadriceps tendon (QT) allografts or QT grafts for non--anterior cruciate ligament reconstruction, evaluated animal models, or failed to identify the proportion of QT grafts when multiple grafts were used.Fig 2Number of publications involving the evaluation or use of quadriceps tendon autografts for reconstruction of the anterior cruciate ligament per year. The color bars represent the type of quadriceps tendon graft discussed in the publication: quadriceps tendon or central quadriceps tendon (QT), quadriceps tendon--bone (QT-B) (or a combination of QT and QT-B), or quadriceps tendon--bone--patellar tendon (QT-B-PT). The data represent the publication count through December 31, 2018.Fig 3Number of publications per journal regarding the evaluation or use of quadriceps tendon autografts for anterior cruciate ligament reconstruction. Journals shown contributed 2 or more publications.Fig 4Number of publications per country. The country of origin was considered the location of the corresponding author's affiliation.Fig 5Number of publications by region. The region was assigned based on the geographical location of the corresponding author's affiliation.Fig 6Level of evidence of clinical publications. Publications that evaluated clinical outcomes (112 of 197) were sorted based on level of evidence (using Oxford Centre for Evidence-Based Medicine guidelines[@bib7]). Values are expressed as a percentage of the clinical publications (n = 112).

Discussion {#sec3}
==========

Through a quantitative and qualitative evaluation of the current literature, this study shows the increasing scientific interest in the QT as a source of autograft tissue for use in ACL reconstruction since its introduction in 1979. The vast majority of studies have been published within the past decade, and higher-quality studies including prospective and randomized controlled trials are a product of recent investigation. Although most publications were published in sports medicine and arthroscopic journals based in the United States and Europe, it is evident that the interest in QT use in ACL reconstruction expands far beyond these regions.

As the pressure continues to mount for physicians to practice evidence-based medicine,[@bib9] it is imperative that graft choice for ACL reconstruction be based on quality clinical research. This evaluation shows increasing interest in research on QT as an alternative graft source. This may have led surgeons to increased use of QT grafts for ACL reconstructions, as reported in recent literature. In a 2010 review, van Eck et al.[@bib10] found that only 2.5% of all ACL reconstructions used QT. In 2014, Middleton et al.[@bib11] found QTs being used in 11% of ACL reconstructions. In addition, our study shows a proportionate shift in the use of central QT grafts versus QT-B and QT-B-PT grafts. This is possibly related to improvement and expansion of the available fixation techniques, which enhances the usability and reliability of an all--soft tissue cylindrical unlooped graft such as the QT graft. The results of our study show increased interest in critical evaluation regarding the use of the QT autograft for ACL reconstruction and substantiate the need for research studies of higher levels of evidence, including randomized controlled trials, comparing the QT with other autograft choices.

Over the past half century, increased research productivity into ACL pathology, surgical techniques, and graft choices has improved the evidence-based practice regarding the treatment of ACL pathology. Many proposed advantages to using the QT for ACL reconstruction have been discussed in the literature. Several studies have evaluated the anatomic qualities of the graft tissue and revealed that the QT has a greater anatomic area for graft harvesting versus patellar tendon grafts.[@bib12]^,^[@bib13] Harris et al.[@bib14] found that greater collagen levels in the QT yielded more favorable biomechanical properties versus patellar tendon grafts of comparable width. Adams et al.[@bib15] showed that the post-harvest strength of the QT was greater than the strength of the intact patellar tendon. Several studies have associated small autograft size with increased failure rates, especially with graft diameters smaller than 8 mm.[@bib16]^,^[@bib17] Thus, a potential surgical advantage to the QT is that it has a larger and more favorable area from which to harvest the graft.[@bib18]

Multiple recently published systematic reviews have supported the use of the QT as a viable alternative graft option based on clinical and functional outcomes after ACL reconstruction.[@bib6]^,^[@bib19]^,^[@bib20] Several recent studies have directly compared the clinical outcomes of QT grafts versus quadrupled hamstring grafts, showing equivalent or superior functional outcomes and less postoperative donor-site pain with QT grafts.[@bib19]^,^[@bib21]^,^[@bib22]

This systematic review shows that since the introduction of the QT autograft by Marshall et al.[@bib4] in 1979, research regarding its use has been increasing steadily. This increase in research reflects the growth in popularity as an alternative choice for autograft tissue in ACL reconstruction. The strengths of this study include the comprehensive search of the literature through the PubMed, Scopus, and Google Scholar databases. Use of these established, public databases gives this study reproducibility and ensures the quality of the included publications. Thus, this evaluation gives an adequate snapshot, through a controlled window, of the state of research into QT autograft use for ACL reconstruction. Future work will include a further systematic literature review and meta-analysis on the research using QT autograft once research studies with higher levels of evidence are conducted and disseminated.

Limitations {#sec3.1}
-----------

This study is not without limitations. Although it does show the increasing volume of published evidence to support QT use in ACL reconstruction, it does not attempt to evaluate or compare the clinical outcomes of QT grafts versus alternative graft sources. In addition, although a rigorous systematic search of the literature was performed, it is possible that not all relevant articles were included in this review.

Conclusions {#sec4}
===========

This evaluation shows the increasing interest in the scientific evaluation of QT as a source of autograft tissue for ACL reconstruction.
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